J Robert Scott expands London office
This article was originally published in Scrip
The Boston-based executive search firm J Robert Scott is expanding its London office, which focuses on the technology and life sciences/healthcare sectors, as well as the investment management sector. Andy Smith has been appointed managing director and head of the London office, and Ben Ayme has been appointed a principal. Mr Smith was previously a partner at Blackwood Group, while Mr Ayme was a director at Veni Partners.
You may also be interested in...
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
An interim analysis of the Phase III KEYNOTE-355 study in triple-negative breast cancer patients reports that first-line pembrolizumab combined with chemotherapy has met the PFS primary endpoint, but Merck & Co is still a long way behind Roche’s Tecentriq in the additional indication.